-
Mashup Score: 17
Implantation of a durable left ventricular assist device (LVAD) in patients with hypertrophic cardiomyopathy (HCM) is technically challenging. We describe our experience using a trans-atrial inflow cannulation and a left atrial-to-aorta (LA-Ao) LVAD configuration. Pump hemodynamics, selection criteria, technical considerations, and postoperative management reflections are discussed.
Source: www.jhltopen.orgCategories: General Medicine NewsTweet
-
Mashup Score: 30Bridging to Orthotopic Heart Transplant: Reducing the Risk of Intra-Operative Blood Loss - 3 month(s) ago
Orthotopic heart transplantation remains the gold standard for patients with end-stage heart failure. Many devices exist to bridge patients with heart failure to transplant. Impella 5.5 (Abiomed, Danvers MA) is an example of a temporary mechanical assist device, which prioritizes patients as Status 2 by the 2018 UNOS policy change, increasing their likelihood of transplantation. Given the increase in device use, we sought to compare intra-operative complications, particularly blood loss, between bridging strategies to transplantation.
Source: www.jhltopen.orgCategories: General Medicine News, CardiologistsTweet-
🔥‼️ proud of our research team @UCSFCTSurgery @UCSFHospitals @UCSFSurgery for this manuscript just published in @TheJHLT looking at decreasing 🩸 loss in heart🫀transplant! https://t.co/dMshDKM9xI
-
-
Mashup Score: 8The impact of donor-recipient age difference on graft survival after heart transplant in adults with congenital heart disease - 9 month(s) ago
The impact of donor-recipient age difference in adult congenital heart disease (ACHD) patients undergoing heart transplant (HT) is unknown.
Source: www.jhltopen.orgCategories: General Medicine News, CardiologistsTweet-
RT @whmarshv: Donor-Recipient Age Difference in ACHD HT Survival https://t.co/e5jrOodOUL https://t.co/RZTUqBezak
-
-
Mashup Score: 4Home Page: JHLT Open - 1 year(s) ago
An Official Publication of the International Society for Heart and Lung Transplantation, JHLT Open brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. As a fully online and Gold
Source: www.jhltopen.orgCategories: General Medicine News, Cardiology News and JournTweet-
Have you checked out the latest science featured in #JHLTOpen? 🔖 Read now at 🔗https://t.co/Q7BHYO1zzP The journal is waiving all Article Processing Charges for all manuscripts submitted through 31 December, 2023. 📆 Submit by the end of the year at 🔗https://t.co/0bcELxEMZp https://t.co/hdnP5XIwsS
-
-
Mashup Score: 17
Patient selection for real-world use of HeartMate 3 left ventricular assist device (HM3 LVAD) differs from that of clinical trials. We assessed adverse-event rates between “nontrial like” (NTL) and “trial like” (TL) patients who underwent commercial HM3 implantation.
Source: www.jhltopen.orgCategories: General Medicine News, CardiologistsTweet-
@RyanTedfordMD @HeartOTXHeartMD @MUSChealth @Jgrewal_12 @TheJHLT @PalakShahMD @manreetkanwar @AHajduczok @fsheikh22 @IRajapreyar @YevgeniyBr @Brian_Houston12 @HajjJennifer @mikerofael Great multicenter collaboration @RyanTedfordMD @Jgrewal_12 , consistent results seen with our center’s experience re: TL and NTL @VQChau20 @lacoyle78 https://t.co/egSOIhvTq8
-
-
Mashup Score: 1Home Page: JHLT Open - 2 year(s) ago
An Official Publication of the International Society for Heart and Lung Transplantation, JHLT Open brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. As a fully online and Gold
Source: www.jhltopen.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Have you checked out the latest science featured in #JHLTOpen? 🔖 Read now at 🔗https://t.co/Q7BHYO1zzP The journal is waiving all Article Processing Charges for all manuscripts submitted through 31 December, 2023. 📆 Submit by the end of the year at 🔗https://t.co/0bcELxEMZp https://t.co/hdnP5XIwsS
-
Very excited to see our latest manuscript published in @TheJHLT Open - Alternative cannulation technique for #LVAD therapy in patients with Hypertrophic Cardiomyopathy with #PierreEmmanuelNoly, Viv Rao, Nicole Fung, @FilioBillia & @BadiwalaMD https://t.co/P6jd0jIizI https://t.co/lPglmuObli